LEO Pharma Investigational site

Québec, Quebec G1W 4R4

1 studies enrolling now · 3 studies all time

What they study most

Atopic Dermatitis, Lichen Sclerosus

Studies at this site

• A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus — Recruiting now
• Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND — Completed
• Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis — Completed